- Chemicals for Life Science -

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.

Home > Products > Novel inhibitors

Cenupatide

Cat. No.: DC11078 Featured

Chemical Structure

1006388-38-0

For research use only. We do not sell to patients.

We match the best price and quality on market.
Email:order@dcchemicals.com sales@dcchemicals.com
Tel:+86-021-58447131

Get Quotation Now

We are official vendor of:

More than 5000 active chemicals with high quality for research!

Field of application

Cenupatide is an urokinase plasminogen activator receptor (uPAR) inhibitor drug candidate. Cenupatide inhibits uPAR binding to the formyl peptide receptors (FPRs) can improve kidney lesions in a rat model of streptozotocin (STZ)-induced diabetes. Cenupati

Chemicals Properties Biological activity Related products COA MSDS Datasheet

Cas No.:	1006388-38-0
Chemical Name:	N2-acetyl-L-arginyl-2-methylalanyl-L-arginyl-α-methylL-phenylalaninamide
Synonyms:	Ac-Arg-Aib-Arg-α(Me)Phe-NH2
SMILES:	CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NC(C)(C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@](C)(CC1=CC=CC=C1)C(=O)N
Formula:	C₂₈H₄₇N₁₁O₅
M.Wt:	617.756
Sotrage:	2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO
Publication:	Plasminogen Activator Inhibitor-1 (PAI-1)

Description:

Cenupatide is an urokinase plasminogen activator receptor (uPAR) inhibitor for treating disorders associated altered cell migration, such as cancer.

Cat. No.	Product name	Field of application
DC11078	Cenupatide	Cenupatide is an urokinase plasminogen activator receptor (uPAR) inhibitor drug candidate. Cenupatide inhibits uPAR binding to the formyl peptide receptors (FPRs) can improve kidney lesions in a rat model of streptozotocin (STZ)-induced diabetes. Cenupati

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.